Self Mobility Improvement in the Elderly by Counteracting Falls (SMILING)

September 19, 2010 updated by: Soroka University Medical Center

Experimental design overview:

The proposed project is a prospective experimental study design. Independent old adults (age 65 years old and older) who suffer from minor balance problems willing to participate in the study will be tested with well-established measuring techniques of balance and gait before and 4 weeks after balance training program using the "Self Mobility Improvement in the Elderly by Counteracting Falls" system (SMILING system). The study design is randomized clinical trial (RCT), cross over, single blinded study design where 30 subjects will randomly be allocated into experimental or control groups that will switch groups after 4 weeks of intervention.

Random sequence generation will be performed by a staff member who will not interact with subjects during the balance-testing sessions. Subjects will be informed that they are to be randomly assigned to one of the two groups, both receiving gait training program.

The staff member who administers the training programs will be the only member of the research team aware of the subjects' group allocations.

A 'blinded' research assistant will administer the balance tests and will perform any data processing that involves subjective judgments.

Scripts will be used during testing to ensure that all subjects receive the same instructions.

Testing session between two training periods (T1) will take one week.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beer-Sheva, Israel, 84105
        • SorokaUMC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

The inclusion criteria are:

Self-reported information

  1. age ≥ 65 years,
  2. able to walk at least 20 meters independently, i.e., without personal assistance and without an assistive device, except for a single point cane
  3. one or more falls in the previous year (falls during sport activities excluded).

Standardized physical and cognitive functional tests

  1. Tinetti's POMA score below 26 (strictly)
  2. MMSE test with score ≥ 24
  3. GDS test with score <10

The exclusion criteria are:

  1. Self-reported information
  2. age < 65 years
  3. inability to walk 20 meters safely (self-report) or walk with personal assistance or with an assistive device (except single point cane for fallers)
  4. inability to recall fall status in the previous year
  5. severe visual impairment (e.g., impaired ability to read, watch TV, or drive a car)
  6. severe hearing impairment (e.g., unable to follow a conversation, to use a phone)
  7. Standardized physical and cognitive functional tests
  8. Tinetti's POMA score less than 19
  9. MMSE score < 24
  10. GDS test with score ≥ 10
  11. Medical conditions (filled in by the family doctor of the subject)
  12. wearing a pacemaker, a cardiac defibrillator or any other electronic implant
  13. severe gait impairment precluding safe walking over 20 meters due to:
  14. focal lower limb muscle weakness or palsy (e.g., unable to raise leg/foot from floor)
  15. neurological diseases, including diseases such as severe Parkinson's disease, Multiple Sclerosis, status post stroke with hemi-syndroma, cervical or lumbar stenosis with compression myelopathy, polyneuropathy with severe proprioceptive impairment, Menier
  16. severe cardiovascular disease
  17. foot problems, lower limb amputation or joint arthrodesis
  18. terminal diseases (defined as estimated life expectancy of less than 6 months).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: balance treatment
The effect of treatment with the SMILING system on postural stability and gait of elderly individuals will be measured using RCT cross over study design

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
gait analysis
Time Frame: time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)

Secondary Outcome Measures

Outcome Measure
Time Frame
Tinetti's performance-oriented mobility assessment (POMA score), CODEX test, GDS test
Time Frame: time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
CODEX test
Time Frame: time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
GDS test
Time Frame: time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
time 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Yakov Grinshpon, MD, Soroka University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

June 1, 2010

Study Completion (Actual)

July 1, 2010

Study Registration Dates

First Submitted

April 7, 2009

First Submitted That Met QC Criteria

April 7, 2009

First Posted (Estimate)

April 8, 2009

Study Record Updates

Last Update Posted (Estimate)

September 21, 2010

Last Update Submitted That Met QC Criteria

September 19, 2010

Last Verified

April 1, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe